Supriya Lifescience Ltd.

356.85 -4.00 ▼-1.1%

23 February 2024, 04:01:00 PM
Volume: 19,323

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.supriyalifescience.com
Market Cap 2,872.43 Cr.
Enterprise Value(EV) 2,756.72 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 14.96 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 23.85 Trailing Twelve Months Ending 2023-12
Industry PE 41.88 Trailing Twelve Months Ending 2023-12
Book Value / Share 97.28 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.67 Calculated using Price: 356.90
Dividend Yield 0.17 Period Ending 2023-03
No. of Shares Subscribed 8.05 Cr. 80,482,800 Shares
FaceValue 2
About Supriya Lifescience Ltd.
The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development. The company has niche product offerings of various APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic.

Supriya Lifescience Ltd. Delivery

Delivered Qty
Traded Qty

Supriya Lifescience Ltd. Performance

1 Day
-1.11%
1 Week
-3.97%
1 Month
+16.62%
3 Month
+42.06%
6 Month
+32.68%
1 Year
+71.23%
2 Year
-6.55%
5 Year
10 Year

Supriya Lifescience Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 29.61 17.2 15.05 18.38 53.11 60.42 59.17 34.34 13.66
Return on Capital Employed (%) 15.83 12.27 11.48 13.8 36.52 49.67 60.12 43.34 18.72
Return on Assets (%) 5.37 2.8 2.4 3.59 15.82 24.9 31.61 25.73 11.56

Supriya Lifescience Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 37 42 46 55 94 149 269 616 699 753
Non Curr. Liab. 23 39 51 45 24 32 31 19 25 24
Curr. Liab. 115 150 144 146 135 155 146 100 96 66
Minority Int.
Equity & Liab. 176 231 241 245 253 336 445 735 820 843
Non Curr. Assets 73 102 126 126 120 138 180 237 355 432
Curr. Assets 103 129 115 120 133 198 265 498 465 411
Misc. Exp. not W/O
Total Assets 176 231 241 245 253 336 445 735 820 843

Supriya Lifescience Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 138 171 184 213 278 312 391 530 461 554
Other Income 2 2 7 9 8 11 5 8 10 10
Total Income 140 173 191 222 286 323 396 538 471 565
Total Expenditure -121 -151 -166 -191 -213 -213 -218 -316 -333 -382
PBIDT 20 22 25 31 73 109 178 222 138 183
Interest -7 -10 -12 -11 -10 -7 -4 -4 -3 -2
Depreciation -2 -4 -5 -5 -5 -6 -7 -10 -12 -15
Taxation -2 -2 -2 -6 -18 -23 -44 -55 -34 -45
Exceptional Items
PAT 8 6 6 9 39 73 124 152 90 120
Adjusted EPS 17 4 4 6 27 50 17 19 11 15

Supriya Lifescience Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -6 14 27 28 49 116 76 49 66
Cash Fr. Inv. -23 -33 -27 -5 5 -25 -47 -60 -133
Cash Fr. Finan. 30 21 -2 -20 -50 -29 -15 150 -3
Net Change 1 2 -2 3 4 62 15 139 -70
Cash & Cash Eqvt 5 7 6 9 12 75 89 228 158

Supriya Lifescience Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 68.24 68.24 68.24 68.24 68.24 68.28 68.30 68.30 68.30
Public 31.76 31.76 31.76 31.76 31.76 31.72 31.70 31.70 31.70
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Supriya Lifescience Ltd. Announcements

Fri, 23 Feb 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find the attachment.
Tue, 20 Feb 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find the attachment.
Tue, 13 Feb 2024
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Please find the attachment.

Supriya Lifescience Ltd. Technical Scans

Fri, 23 Feb 2024
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Month High Close Above Last Month High
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Supriya Lifescience Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 374,572.18 1,560.95 +0.2%
Cipla Ltd. 118,375.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. 107,511.08 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. 97,345.81 6,742.15 -0.4%
Divi's Laboratories Ltd. 96,748.70 3,636.05 -0.3%
Zydus Lifesciences Ltd. 93,335.34 922.10 +1.9%
Torrent Pharmaceuticals Ltd. 88,913.00 2,627.10 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.06 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 31.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.56 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.33 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 69.96 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.39 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.51 2,627.10 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.00 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 4.57 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 7.42 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.80 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.43 2,627.10 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,627.10 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,627.10 +0.7%

Supriya Lifescience Ltd. FAQ's

What is Supriya Lifescience share price?

Can I buy Supriya Lifescience shares now?

What is the Dividend Yield of Supriya Lifescience?

What is the Market Cap of Supriya Lifescience?

What are the key metrics to analyse Supriya Lifescience?

What is the 52 Week High and Low of Supriya Lifescience?

What is the trend of Supriya Lifescience share price?